For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.
Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...
Hosted on MSN23d
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With EstimatesThis quarter, Elevance Health grew its revenue by 6.6% year on year, and its $45.44 billion of revenue was in line with Wall Street’s estimates. Looking ahead, sell-side analysts expect revenue to ...
Buying $100 In ELV: If an investor had bought $100 of ELV stock 20 years ago, it would be worth $646.73 today based on a ...
Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...
GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...
Shares of Elevance Health Inc. ELV slipped 2.91% to $390.47 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to ...
Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a spokesperson for Elevance confirmed to Fierce Healthcare. | Elevance Health has ...
UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records ...
Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results